参考文献/References:
[1]Annett S,Moore G,Short A,et al.FKBPL-based peptide,ALM201,targets angiogenesis and cancer stem cells in ovarian cancer[J].Br J Cancer,2020,122(3):361-371.[2]Nusrat O,Belotte J,Fletcher NM,et al.The Role of Angiogenesis in the Persistence of Chemoresistance in Epithelial Ovarian Cancer[J].Reprod Sci,2016,23(11):1484-1492.[3]Gordon J,Chapus FL,Viverette EG,et al.Cryo-EM reveals the architecture of the PELP1-WDR18 molecular scaffold[J].Nat Commun,2022,13(1):6783.[4]黄吉仁,李长江,毛艳华,等.PELP1、SETDB1在卵巢癌组织中的表达及意义[J].重庆医学,2023,52(20):3099-3103,3109.[5]Zhu J,Wang L,Liu F,et al.Targeting PELP1 Attenuates Angiogenesis and Enhances Chemotherapy Efficiency in Colorectal Cancer[J].Cancers(Basel),2022,14(2):383.[6]王稳,马军霞,崔秀娟,等.VEGF、HIF-1α与上皮性卵巢癌血管生成及生物学行为的关系[J].中华养生保健,2023,41(20):10-13.[7]刘星辰,蔡俊,刘忠强.上皮性卵巢癌组织中MSLN、ERBB2表达及其临床意义[J].实用癌症杂志,2024,39(5):738-741.[8]Zeng Z,Lin C,Zhang MC,et al.Enterolactone and trabectedin suppress epithelial ovarian cancer synergistically via upregulating THBS1[J].Phytother Res,2023,37(10):4722-4739.[9]Ding Y,Zhuang S,Li Y,et al.Hypoxia-induced HIF1α dependent COX2 promotes ovarian cancer progress[J].J Bioenerg Biomembr,2021,53(4):441-448.[10]Melincovici CS,Boｓca AB,Suｓman S,et al.Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis[J].Rom J Morphol Embryol,2018,59(2):455-467.[11]Lim D,Do Y,Kwon BS,et al.Angiogenesis and vasculogenic mimicry as therapeutic targets in ovarian cancer[J].BMB Rep,2020,53(6):291-298.[12]Englert-Golon M,Andrusiewicz M,Zbikowska A,et al.Altered Expression of ESR1, ESR2,PELP1 and c-SRC Genes Is Associated with Ovarian Cancer Manifestation[J].Int J Mol Sci,2021,22(12):6216.[13]Gonugunta VK,Miao L,Sareddy GR,et al.The social network of PELP1 and its implications in breast and prostate cancers[J].Endocr Relat Cancer,2014,21(4):T79-T86.[14]Zhang D,Dai J,Pan Y,et al.Overexpression of PELP1 in Lung Adenocarcinoma Promoted E2 Induced Proliferation, Migration and Invasion of the Tumor Cells and Predicted a Worse Outcome of the Patients[J].Pathol Oncol Res,2021,27:582443.[15]Luo Y,Li M,Pratap UP,et al.PELP1 signaling contributes to medulloblastoma progression by regulating the NF-κB pathway[J].Mol Carcinog,2020,59(3):281-292.[16]Stachelscheid J,Jiang Q,Aszyk C,et al.The proto-oncogene TCL1A deregulates cell cycle and genomic stability in CLL[J].Blood,2023,141(12):1425-1441.[17]Orellana EA,Liu Q,Yankova E,et al.METTL1-mediated m7G modification of Arg-TCT tRNA drives oncogenic transformation[J].Mol Cell,2021,81(16):3323-3338.[18]赵宝山,梁冠盈,许圣洁,等.PELP1表达与胃癌演进及预后相关性分析[J].实用肿瘤学杂志,2022,36(1):31-36.[19]邢其棋,张芳,刘栋,等.常见泪腺上皮性肿瘤中EGFL7的表达及其与血管生成和细胞增殖活性的相关性研究[J].国际眼科杂志,2020,20(7):1139-1142.
相似文献/References:
[1]何 静.上皮性卵巢癌化学治疗的研究[J].医学信息,2019,32(18):24.[doi:10.3969/j.issn.1006-1959.2019.18.009]
HE Jing.Chemotherapy of Epithelial Ovarian Cancer[J].Journal of Medical Information,2019,32(07):24.[doi:10.3969/j.issn.1006-1959.2019.18.009]
[2]唐 帆,郭桂兰.PAX8与上皮性卵巢癌的关系研究[J].医学信息,2022,35(06):63.[doi:10.3969/j.issn.1006-1959.2022.06.016]
TANG Fan,GUO Gui-lan.Relationship Between PAX8 and Epithelial Ovarian Cancer[J].Journal of Medical Information,2022,35(07):63.[doi:10.3969/j.issn.1006-1959.2022.06.016]
[3]谭金城,王羽丰,高 霞,等.上皮性卵巢癌中T淋巴细胞的浸润特征[J].医学信息,2022,35(15):164.[doi:10.3969/j.issn.1006-1959.2022.15.039]
TAN Jin-cheng,WANG Yu-feng,GAO Xia,et al.Infiltration Characteristics of T Lymphocytes in Epithelial Ovarian Cancer[J].Journal of Medical Information,2022,35(07):164.[doi:10.3969/j.issn.1006-1959.2022.15.039]